Form 4: Zoetis Executive Roxanne Lagano Reports Acquisition of Phantom Stock Units

Executive Vice President Roxanne Lagano reports acquiring phantom stock units in Zoetis Inc. through the company's Supplemental Savings Plan.

Summary

• Roxanne Lagano, an Executive Vice President at Zoetis Inc., filed a Form 4 disclosing a transaction involving phantom stock units.
• On April 4, 2025, Lagano acquired 466.7025 phantom stock units pursuant to the Zoetis Supplemental Savings Plan.
• These units are settled in cash following separation from service and can be transferred to alternative investment funds, subject to Zoetis's limitations.
• Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, with the value tied to the market value of Zoetis common stock and the cash-equivalent investments.
• Following the reported transaction, Lagano beneficially owns 28,264.1826 phantom stock units.
• The price of the phantom stock unit was $49.66.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard executive compensation practices. It doesn't contain any particularly positive or negative news, but the acquisition of phantom stock units suggests confidence in the company's future performance.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Zoetis Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's success.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Executive compensation packages often include phantom stock units as a way to incentivize performance and align executive interests with shareholder value, similar to practices at companies like Merck & Co. and Eli Lilly.
• Supplemental savings plans are common in large corporations to provide additional retirement savings opportunities for employees, comparable to plans offered by Pfizer and Johnson & Johnson.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive compensation with company performance.

Key Dates

Keywords

Form 4, Zoetis, Phantom Stock Units, Executive Compensation, Supplemental Savings Plan, Roxanne Lagano, ZTS